Inmode LtdNASDAQ:INMD
- LAST PRICE19.4900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots19.4900/ 6
- Ask / Lots19.5000/ 10
- Open / Previous Close19.5900 / 19.4900
- Day Range
- 52 Week Range
- Volume31,326
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | INMD |
|---|---|---|
| 09:32 ET | 9741 | 19.58 |
| 09:33 ET | 4722 | 19.54 |
| 09:35 ET | 7751 | 19.49 |
| 09:37 ET | 100 | 19.49 |
Nov 6, 2024
InMode to Present at Upcoming Investor Conferences, from 8:30AM ET on Wednesday Nov 06, 2024 by Dow Jones
8:30AM ET on Wednesday Nov 06, 2024 by Dow Jones
Oct 30, 2024
InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024), from 7:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
7:00AM ET on Wednesday Oct 30, 2024 by Dow Jones*DJ InMode 3Q EPS 65c >INMD, from 7:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
7:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Inmode Ltd | 1.5B | 10.6x | +45.75% |
iRhythm Technologies Inc | 2.6B | -18.1x | --- |
Accuray Inc | 197.1M | -10.5x | --- |
TruBridge Inc | 252.7M | -4.3x | --- |
Cytek Biosciences Inc | 825.7M | -83.0x | --- |
LeMaitre Vascular Inc | 2.4B | 58.2x | +3.81% |
Company Information
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Contact Information
- Headquarters
- Tavor Building, Sha'ar Yokneam, Pob 533YOKNEAM, Israel 2069200
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Michael Anghel
- Chief Executive Officer, Director
- Moshe Mizrahy
- Chief Financial Officer
- Yair Malca
- President, North America
- Shakil Lakhani
- Chief Technology Officer, Director
- Michael Kreindel
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5B |
|---|---|
Revenue (TTM) | $423.7M |
Shares Outstanding | 76.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.08 |
EPS | $1.85 |
Book Value | $9.38 |
P/E Ratio | 10.6x |
Price/Sales (TTM) | 3.5 |
Price/Cash Flow (TTM) | 9.5x |
Operating Margin | 32.07% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
